Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $191,431,274,975 | $199,363,368,559 | $209,139,369,524 | $190,952,423,012 |
| - Cash | $4,838 | $3,767 | $3,319 | $4,995 |
| + Debt | $4 | $0 | $429 | $599 |
| Enterprise Value | $191,431,270,141 | $199,363,364,792 | $209,139,366,634 | $190,952,418,616 |
| Revenue | $116 | $14,683 | $17,093 | $15,024 |
| % Growth | -99.2% | -14.1% | 13.8% | – |
| Gross Profit | $50 | $6,624 | $5,017 | $6,792 |
| % Margin | 42.8% | 45.1% | 29.4% | 45.2% |
| EBITDA | $12 | $1,806 | $2,240 | $1,790 |
| % Margin | 10.2% | 12.3% | 13.1% | 11.9% |
| Net Income | $8 | $1,391 | $1,517 | $1,304 |
| % Margin | 7.2% | 9.5% | 8.9% | 8.7% |
| EPS Diluted | 0.3 | 49.48 | 53.97 | 46.39 |
| % Growth | -99.4% | -8.3% | 16.3% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |